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Long-Term Safety of Ranolazine
Ranolazine, a novel anti-anginal agent, has shown good efficacy for relief ofsymptoms, but there is little data on long-term safety. Koren and colleagues
followed almost 800 patients receiving open-label ranolazine for 2 years. No patients
dropped out due to electrocardiographic abnormalities. The 2-year survival of 94.4%
compares favorably with an estimated survival of 90% based on their Duke Treadmill
Scores. This nonrandomized, nonblinded study helps to alleviate some concerns




Inhibition Compared to Ezetimibe Combination Therapy
Whereas the clinical benefits of statins are well known, there remains debate as tothe importance of low-density lipoprotien (LDL) lowering versus pleiotropic
effects. Piorkowski and colleagues randomized 50 patients to either atorvastatin 40mg
daily or atorvastatin 10 mg plus ezetimibe and measured platelet reactivity at baseline
and after 4 weeks. All patients recieved combination therapy with clopidogrel and
aspirin. The effects on the cholesterol profile were similar, but high-dose atorvastatin
resulted in significant improvements in measures of platelet reactivity compared with
baseline and with combination therapy. This small study suggests that the pleiotropic,
rather than the LDL-lowering, effects of high-dose atorvastatin result in improved
platelet inhibition. See page 1035. See figure.
Cardiac Imaging
Integrated SPECT/CT Device Compared With Coronary Angiography
Hybrid single-photon emission computed tomography (SPECT)/CT devicesoffer the potential to combine the prognostic value of nuclear perfusionwith the
anatomic information from CT angiography in one study. Furthermore, the attenua-
tion information from the CT can be used to increase the specificity of the perfusion
data. Rispler and colleagues compared SPECT/CT with conventional coronary an-
giography in 56 patients. Twenty-three percent of coronary segments had to be
excluded,mostly because ofmotion artifact affecting theCT images. Compared toCT
alone, the integrated SPECT/CT improved the specificity from 63% to 95% and the
positive predictive value from 33% to 77%. This study demonstrates that combining
SPECT with CT angiography can substantially improve specificity and positive pre-
dictive value. See page 1059.
(continued) A-32Page 1072
Heart Failure and BNP
Clues to the BNP Paradox
One of the paradoxes of heart failure physiology is why patients with elevatedB-type natriuretic peptide (BNP) levels seem to not have the beneficial effects of
BNP on reducing congestion and edema. Liang and colleagues studied plasma from 5
patients with congestive heart failure and found that most of the circulating BNP is
actually the uncleaved proBNP. In cell culture assays, this proBNP is 6 to 8 times less
physiologically active than BNP. They hypothesize that the increased production of
proBNP may overwhelm the ability of cardiac myocytes to process it to the mature
peptide, thereby resulting in the release of significant amounts of the less physiologi-
cally active proBNP. See page 1071. See figure.
Page 1095
Heart Rhythm Disorders
LQTS Risk Reduced During Pregnancy, Higher in Postpartum Period
Little is known about the risks of pregnancy for females with long QT syndrome(LQTS). Seth and colleagues studied the risk of experiencing an adverse cardiac
event, including syncope, aborted cardiac arrest, and sudden death, during and after
pregnancy in almost 400 women. During pregnancy, the risk of an adverse event was
only one-quarter of the pre-pregnancy risk. However, the risk was almost 3 times
higher in the 9months after delivery. The riskswere higher for subjects with the LQT2
genotype andwere reduced by beta-blockers. This study suggests that pregnancy is safe
for women with LQTS but there is a need for increased vigilance during the postpar-
tum period. See page 1092. See figure.
